• Demand for single-use intermittent catheters continues to rise, with utilization increasing by more than 35% due to heightened infection-prevention awareness and stricter clinical hygiene protocols across care settings.

• Adoption of hydrophilic-coated catheters has grown by over 40%, driven by reduced urethral trauma, improved patient comfort, and strong clinical evidence supporting lowered catheter-associated complication rates.

• Chronic conditions such as neurogenic bladder dysfunction are driving sustained demand, with intermittent catheterization recommended in more than 50% of long-term bladder-management cases for safer and controlled drainage.

• Home-care usage has increased by nearly 30% as patients shift toward self-catheterization supported by telehealth follow-ups, improved patient education, and higher availability of pre-lubricated, easy-to-use designs.

• Healthcare systems integrating infection-control-focused catheter solutions report reductions in UTI incidence exceeding 20%, contributing to higher adoption among hospitals and outpatient clinics.

• Manufacturers embracing eco-friendly materials and minimal-plastic catheter designs are seeing interest growth above 18%, reflecting rising demand for sustainable medical disposables.

• Reimbursement coverage improvements have driven purchasing confidence, with reimbursement-supported catheter usage increasing by approximately 25% across adult and geriatric patient groups requiring long-term urinary management.

• In March 2021, Bactiguard presented results from a published, controlled multicenter study in India, demonstrating that its urinary catheters reduced the risk of catheter-associated urinary tract infections (CAUTI) by 69% compared to standard catheters.

• In February 2021, UroDev Medical, a medical device company, appointed experienced medical device executive Matt Monarski as its Chief Executive Officer. The company also relocated its headquarters from San Clemente, California, to Minneapolis.

In this report, the Intermittent Catheters Market has been segmented by Product, Indication, End Users and Geography. These segments highlight how patient needs, clinical protocols, infection-control standards and hospital purchasing strategies shape the adoption of intermittent catheter solutions across global healthcare systems.

Intermittent Catheters Market, Segmentation by Product

The Product segmentation includes Uncoated Intermittent Catheter and Coated Intermittent Catheter, the latter further divided into Antimicrobial, Hydrophilic and Others. Increasing emphasis on infection prevention, ease of insertion and patient comfort drives product evolution, with coated catheters accounting for nearly 55% of new clinical preferences due to their lower contamination risk.

Uncoated Intermittent Catheter

Uncoated catheters are widely used due to their cost-effectiveness and clinical reliability. They remain preferred in hospitals prioritizing standard catheterization protocols. Adoption is stable—representing nearly 40% of total usage—supported by availability across multiple sizes and materials.

Coated Intermittent Catheter

Coated catheters gain rapid traction due to enhanced lubrication, reduced urethral trauma and lower infection risk. Hospitals increasingly adopt coated variants, especially for long-term catheter users and post-surgical patients.

• Antimicrobial

  Antimicrobial catheters help reduce catheter-associated urinary tract infections (CAUTIs) through specialized coatings that suppress bacterial colonization. Adoption grows nearly 30% annually as hospitals strengthen infection-control measures.

• Hydrophilic

  Hydrophilic catheters feature pre-lubricated surfaces that expand when exposed to water, significantly reducing friction during insertion. These devices account for nearly 35% of coated catheter demand due to high patient acceptance and improved safety.

• Others

  This category includes silicone-coated and polymer-enhanced catheters designed for specialty cases. Adoption increases steadily as manufacturers introduce ergonomic designs and single-use safety formats to improve compliance.

Intermittent Catheters Market, Segmentation by Indication

The Indication segmentation includes Urinary Incontinence, Surgery (Major Surgery), Spinal Cord Injury and Others. Rising prevalence of neurogenic bladder disorders, post-operative urinary challenges and age-related incontinence drives strong demand across all clinical categories, with urology accounting for nearly 50% of total catheter usage.

Urinary Incontinence

Urinary incontinence remains a major driver as patients require regular catheterization for bladder emptying. Adoption increases nearly 35% due to growing awareness of self-catheterization and improved comfort through coated products.

Surgery (Major Surgery)

Post-operative patients, especially those undergoing orthopedic, abdominal or pelvic procedures, often require intermittent catheterization. Hospitals adopt low-trauma catheters to reduce infection risks, supporting nearly 25% demand within this category.

Spinal Cord Injury

Spinal cord injury patients rely heavily on intermittent catheterization for bladder management. This group drives nearly 30% of total demand for high-lubricity and infection-resistant catheter solutions due to long-term dependence.

Others

Other indications include chronic retention, prostate-related complications and neurological disorders. Adoption rises as clinicians increasingly recommend personalized catheter regimens to improve long-term urinary health.

Intermittent Catheters Market, Segmentation by End Users

The End Users segmentation includes Hospitals, Medical Research Centers and Ambulatory Surgical Center. Growing focus on infection prevention, patient mobility and cost-efficient consumables drives adoption across all facility types, with hospitals contributing nearly 60% of global demand.

Hospitals

Hospitals rely extensively on intermittent catheters for in-patient care, post-operative protocols and emergency medicine. Demand remains dominant due to high patient turnover and the need for reliable, sterile catheter systems.

Medical Research Centers

Medical research centers utilize intermittent catheters in clinical trials, urology studies and product-performance evaluations. Adoption rises nearly 20% as new coatings, materials and usability features are tested for regulatory approvals.

Ambulatory Surgical Center

Ambulatory centers use intermittent catheters for day-care surgeries and short-term urinary management. Growth accelerates with nearly 25% demand as outpatient procedures increase globally.

Intermittent Catheters Market, Segmentation by Geography

The market is segmented by Geography into North America, Europe, Asia Pacific, Middle East & Africa and Latin America. Regional demand is shaped by healthcare spending, aging populations, urology caseloads and reimbursement strength, with mature markets accounting for nearly 65% of total catheter adoption.

North America

North America holds the largest share with nearly 35% adoption driven by strong urology caseloads, high chronic-care prevalence and widespread availability of premium coated catheters. Favorable reimbursement also strengthens growth.

Europe

Europe maintains strong demand due to aging demographics and established infection-control standards. Nearly 30% of regional usage comes from long-term care and hospital settings.

Asia Pacific

Asia Pacific demonstrates rapid expansion, driven by rising healthcare expenditure and improved access to urology care. Nearly 25% of growth is attributed to increasing awareness of self-catheterization practices.

Middle East & Africa

MEA adoption grows steadily as healthcare modernization expands urology treatment availability. Demand rises for cost-efficient catheter solutions and infection-reduction technologies across public hospitals.

Latin America

Latin America experiences increasing adoption as chronic-care management improves. Demand rises for high-quality coated catheters and affordable uncoated variants across both public and private facilities.

This report provides an in depth analysis of various factors that impact the dynamics of Global Intermittent Catheters Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers

• Growing aging population globally
• Rising prevalence of urinary disorders
• Technological advancements in products

• Increasing awareness and healthcare expenditure: The global intermittent catheters market is experiencing significant growth due to increasing awareness and rising healthcare expenditure. Intermittent catheters, designed for patients with urinary retention issues, have become more widely recognized as a crucial tool in managing bladder dysfunction. As public awareness increases through educational campaigns and medical professionals’ efforts to inform patients about the benefits of these devices, demand continues to rise. Additionally, the aging global population, which is more susceptible to urinary incontinence and other related conditions, further drives market expansion.

  Healthcare expenditure is another key factor propelling the intermittent catheters market forward. Governments and private sectors worldwide are investing more in healthcare infrastructure and services, recognizing the importance of improving quality of life for individuals with chronic health conditions. These investments lead to better access to medical devices, including intermittent catheters, and foster innovation in the development of more user-friendly and effective products. Enhanced healthcare spending also supports training for healthcare providers, ensuring that they are well-equipped to recommend and instruct patients in the proper use of intermittent catheters.

  Technological advancements in catheter design and materials have contributed to market growth. Modern intermittent catheters are becoming more comfortable, easier to use, and less likely to cause infections, which addresses common concerns among patients. Manufacturers are focusing on developing products that offer superior performance and safety features, such as hydrophilic coatings and antibacterial properties. These innovations not only improve patient compliance but also attract a broader consumer base. Consequently, the combination of increased awareness, heightened healthcare expenditure, and technological progress is expected to sustain the upward trajectory of the global intermittent catheters market in the coming years.

Restraints

• High cost of devices
• Risk of urinary tract infections
• Limited reimbursement policies

• Availability of alternatives: The global intermittent catheters market has experienced significant growth in recent years, driven by factors such as increasing prevalence of urinary incontinence, spinal cord injuries, and neurological disorders. However, one of the key challenges faced by this market is the availability of alternatives. While intermittent catheters are widely used and considered effective in managing bladder dysfunction, there are alternative treatment options that cater to specific patient needs and preferences.

  One alternative to intermittent catheterization is indwelling catheters, also known as Foley catheters, which remain in the bladder for an extended period. While indwelling catheters offer convenience by eliminating the need for frequent catheterizations, they are associated with a higher risk of urinary tract infections and other complications. Additionally, some patients may prefer alternative management strategies such as medications, behavioral therapies, or surgical interventions depending on the underlying condition and individual circumstances.

  Another emerging alternative in the management of urinary dysfunction is the use of advanced technologies such as sacral neuromodulation and botulinum toxin injections. Sacral neuromodulation involves the implantation of a device that delivers electrical stimulation to the sacral nerves, modulating bladder function and reducing urinary symptoms. Botulinum toxin injections into the bladder wall can also help relax the muscles and improve bladder capacity, particularly in patients with neurogenic bladder conditions. While these alternatives may offer promising outcomes for certain patient populations, they may not be suitable or accessible for all individuals due to factors such as cost, invasiveness, and availability of specialized healthcare services.

Opportunities

• Emerging markets expansion
• Product innovation and development
• Government healthcare initiatives

• Increasing home healthcare demand: The global intermittent catheters market is experiencing significant growth, primarily fueled by the increasing demand for home healthcare services. As the population ages and the prevalence of urinary retention and incontinence rises, there's a growing need for convenient and effective solutions for managing these conditions. Intermittent catheters have emerged as a vital tool in the management of urinary issues, offering patients a way to empty their bladders comfortably and hygienically.

  One of the key drivers behind the rising demand for intermittent catheters is the shift towards home-based healthcare services. With advancements in medical technology and an emphasis on patient-centered care, many individuals prefer receiving treatment in the comfort of their own homes. Intermittent catheters enable patients to perform catheterization independently or with minimal assistance, empowering them to maintain their independence and quality of life while managing their urinary health.

  Intermittent catheters play a crucial role in reducing the need for frequent hospital visits or lengthy stays, allowing patients to receive necessary care while minimizing exposure to potential infections. As a result, the global intermittent catheters market is witnessing robust growth, with manufacturers innovating to enhance product features, such as ease of use, comfort, and infection control, to meet the evolving needs of patients and healthcare providers alike.

Intermittent Catheters Market is witnessing strong growth driven by increasing adoption of urology care solutions and advanced technological advancements. Leading companies focus on innovation to capture over 40% of market share, while mergers and strategic partnerships strengthen positioning and ensure a robust future outlook.

Market Structure and Concentration
The market exhibits a moderately concentrated structure, with top players holding more than 50% of total share. Strategic mergers and acquisitions are fueling growth, while emerging companies leverage innovation to expand presence. Collaborative strategies enhance efficiency and support long-term expansion.

Brand and Channel Strategies
Leading brands implement multi-channel strategies and form strong partnerships to boost market penetration. Distribution networks contribute over 35% of revenue. Continuous innovation in catheter design, material safety, and patient comfort drives sustained growth across hospitals, clinics, and home care settings.

Innovation Drivers and Technological Advancements
Technological advancements are key drivers, contributing more than 45% to R&D initiatives. Companies focus on innovation in hydrophilic coatings, anti-microbial materials, and ergonomic designs. Collaborative strategies accelerate development and ensure a strong future outlook for intermittent catheters.

Regional Momentum and Expansion
Certain regions show faster expansion due to rising urology disorders and healthcare infrastructure. Strategic partnerships and localized innovation account for over 30% of regional market share. Companies invest in growth initiatives to strengthen presence and maintain long-term competitive advantage.

Future Outlook
The future outlook for the intermittent catheters market is promising, with technological advancements and innovation expected to drive over 50% of market expansion. Strategic collaborations and mergers will continue shaping the competitive landscape, ensuring sustainable growth and leadership across key regions.

Key players in Intermittent Catheters Market include:

• Coloplast A/S
• Hollister Incorporated
• B. Braun Melsungen AG
• Teleflex Incorporated
• Convatec Group PLC
• C.R. Bard
• Medtronic plc
• Boston Scientific Corporation
• Wellspect Healthcare
• Teleflex Medical OEM

In this report, the profile of each market player provides following information:

• Market Share Analysis
• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis